Arrivo BioVentures
Morrisville, US · Founded 2015 · 15 employees on LinkedIn · 3 known investors
Find your way into Arrivo BioVentures
Sign up to find every way you can get introduced to Arrivo BioVentures
- Your email: who you already know at Arrivo BioVentures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Arrivo BioVentures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Arrivo Bio develops novel, disease-modifying medicines targeting the root cause of hard-to-treat diseases for which few effective treatment options exist. The company partners with Mayo Clinic and Daiichi Sankyo to advance first-of-its-kind therapies.
Founders & leadership
Investors · 3
How we know: Rex Health Ventures's portfolio page · the company's own site · funding news · Not right? Tell us
How we know: the company's own site · funding news · Not right? Tell us
How we know: Solas BioVentures's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$43.2M disclosed across 1 round · 2023
▶$43.2MraisedNov 2023 · 58 investors · BiotechnologyRule 506(b)
- Karen AdamsExecutive Officer
- Stephen E. ButtsExecutive Officer
- Offering amount
- $45.3M
- Amount sold
- $43.2M
- First sale
- Nov 2023
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Arrivo BioVentures do?
- Arrivo Bio develops novel, disease-modifying medicines targeting the root cause of hard-to-treat diseases for which few effective treatment options exist. The company partners with Mayo Clinic and Daiichi Sankyo to advance first-of-its-kind therapies.
- Who are Arrivo BioVentures's investors?
- Arrivo BioVentures's investors include Rex Health Ventures, Orlando Health Ventures, Solas BioVentures.
- How much funding has Arrivo BioVentures raised?
- Arrivo BioVentures has disclosed $43.2M raised across 1 round.
- Where is Arrivo BioVentures headquartered?
- Arrivo BioVentures is headquartered in Morrisville, US.

